119 related articles for article (PubMed ID: 34328086)
41. [The efficacy of and tolerance for ketoprofen lysine salt in solution for oropharyngeal use in inflammatory lesions of the oral cavity].
Natale F; de' Lorenzi C
Minerva Stomatol; 1997 May; 46(5):273-8. PubMed ID: 9265098
[TBL] [Abstract][Full Text] [Related]
42. Beneficial effects of Camellia Oil (Camellia oleifera Abel.) on ketoprofen-induced gastrointestinal mucosal damage through upregulation of HO-1 and VEGF.
Cheng YT; Wu SL; Ho CY; Huang SM; Cheng CL; Yen GC
J Agric Food Chem; 2014 Jan; 62(3):642-50. PubMed ID: 24377395
[TBL] [Abstract][Full Text] [Related]
43. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
[TBL] [Abstract][Full Text] [Related]
44. Protective activity of ketoprofen lysine salt against the pulmonary effects induced by bradykinin in guinea-pigs.
Daffonchio L; Rossoni G; Clavenna G; Omini C; Berti F
Inflamm Res; 1996 May; 45(5):259-64. PubMed ID: 8737750
[TBL] [Abstract][Full Text] [Related]
45. Mechanistic perspective of morin protection against ketoprofen-induced gastric mucosal injury: Targeting HMGB1/RAGE/NF-κB, DJ-1/Nrf2/HO-1 and PI3K/mTOR pathways.
Arab HH; Saad MA; El-Sahar AE; Al-Shorbagy MY
Arch Biochem Biophys; 2020 Oct; 693():108552. PubMed ID: 32860758
[TBL] [Abstract][Full Text] [Related]
46. Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.
Tubaro E; Belogi L; Mezzadri CM; Ruco L; Stopacciaro A
Arzneimittelforschung; 1995 Dec; 45(12):1298-302. PubMed ID: 8595088
[TBL] [Abstract][Full Text] [Related]
47. Dose-dependent effects of ketoprofen on the human gastric mucosa in comparison with ibuprofen.
Donnelly MT; Richardson P; Hawkey CJ; Courtauld E; Stack WA
Aliment Pharmacol Ther; 2000 May; 14(5):543-9. PubMed ID: 10792116
[TBL] [Abstract][Full Text] [Related]
48. [Use of the NSAID ketoprofen lysine salt in glucose-6-phosphate dehydrogenase (G6PD) deficiency in inflammatory disease in children].
Corda R; Carnelli V
Pediatr Med Chir; 1996; 18(4):391-4. PubMed ID: 9064672
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of ketoprofen lysine salt and paracetamol/acetaminophen to reduce pain during rapid maxillary expansion: A randomized controlled clinical trial.
Cossellu G; Lanteri V; Lione R; Ugolini A; Gaffuri F; Cozza P; Farronato M
Int J Paediatr Dent; 2019 Jan; 29(1):58-65. PubMed ID: 30298560
[TBL] [Abstract][Full Text] [Related]
50. Gastroprotective effect of crocin in ethanol-induced gastric injury in rats.
El-Maraghy SA; Rizk SM; Shahin NN
Chem Biol Interact; 2015 Mar; 229():26-35. PubMed ID: 25637687
[TBL] [Abstract][Full Text] [Related]
51. Gastroprotective effect of L-carnitine on indomethacin-induced gastric mucosal injury in rats: a preliminary study.
Erkin B; Dokmeci D; Altaner S; Turan FN
Folia Med (Plovdiv); 2006; 48(3-4):86-9. PubMed ID: 17668703
[TBL] [Abstract][Full Text] [Related]
52. Enhanced Analgesic Effects and Gastrointestinal Safety of a Novel, Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids.
Costa SKPF; Muscara MN; Allain T; Dallazen J; Gonzaga L; Buret AG; Vaughan DJ; Fowler CJ; de Nucci G; Wallace JL
Antioxid Redox Signal; 2020 Nov; 33(14):1003-1009. PubMed ID: 32064887
[No Abstract] [Full Text] [Related]
53. [Pharmacologic and pharmacokinetic activity of ketoprofen lysine salt for topical administration].
Borsa M; Malandrino S; Ronchi C; Tonon GC; Zanolo G
Farmaco Prat; 1983 Feb; 38(2):87-96. PubMed ID: 6403380
[No Abstract] [Full Text] [Related]
54. [Ketoprofen lysine treatment of painful manifestations of spinal osteoarthrosis].
Memeo A; Cosentina R
Clin Ter; 1988 Jul; 126(2):119-22. PubMed ID: 2974377
[No Abstract] [Full Text] [Related]
55. Selective scavenging of intra-mitochondrial superoxide corrects diclofenac-induced mitochondrial dysfunction and gastric injury: A novel gastroprotective mechanism independent of gastric acid suppression.
Mazumder S; De R; Sarkar S; Siddiqui AA; Saha SJ; Banerjee C; Iqbal MS; Nag S; Debsharma S; Bandyopadhyay U
Biochem Pharmacol; 2016 Dec; 121():33-51. PubMed ID: 27693316
[TBL] [Abstract][Full Text] [Related]
56. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
57. Gastroprotective activity of Zanthoxylum rhoifolium Lam. in animal models.
Freitas FF; Fernandes HB; Piauilino CA; Pereira SS; Carvalho KI; Chaves MH; Soares PM; Miura LM; Leite JR; Oliveira RC; Oliveira FA
J Ethnopharmacol; 2011 Sep; 137(1):700-8. PubMed ID: 21723384
[TBL] [Abstract][Full Text] [Related]
58. [Evaluation of the neurotoxic effects of intrathecal administration of (S)-(+)-Ketoprofen on rat spinal cords: randomized controlled experimental study].
Kaya C; Atalay YO; Meydan BC; Ustun YB; Koksal E; Caliskan S
Braz J Anesthesiol; 2019; 69(4):403-412. PubMed ID: 31371174
[TBL] [Abstract][Full Text] [Related]
59. Encapsulation of ketoprofen and ketoprofen lysinate by prilling for controlled drug release.
Del Gaudio P; Russo P; Rosaria Lauro M; Colombo P; Aquino RP
AAPS PharmSciTech; 2009; 10(4):1178-85. PubMed ID: 19856108
[TBL] [Abstract][Full Text] [Related]
60. Intestinal ulcerogenic effect of S(+)-ketoprofen in the rat.
Cabré F; Fernández F; Zapatero MI; Araño A; García ML; Mauleón D
J Clin Pharmacol; 1998 Dec; 38(S1):27S-32S. PubMed ID: 9882079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
